| Exercise and Irritable Bowel Syndrome (IBS) (NCT05453084) | Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis | 2022-05-02 |
| Study on Treatment Mechanisms and Efficacy Prediction of Individualized Transcranial Magnetic Stimulation in Adults With Irritable Bowel Syndrome Using Multimodal MRI and High-Throughput Sequencing (NCT07345377) | The Affiliated Hospital of Hangzhou Normal University | 2022-01-01 |
| Quest to Analyze One Thousand Humans Meditating (NCT06583395) | Tobias Moeller-Bertram | 2021-12-05 |
| The Effect of Inulin in Irritable Bowel Syndrome (NCT06610188) | Mardin Artuklu University | 2021-11-03 |
| Butyrate in Children With IBS: Double Blind Placebo Controlled Randomized Clinical Trial (NCT04566679) | University of Bari | 2021-04-21 |
| Evaluate the Safety of Linaclotide in IBS-C Patients in China (NCT04462900) | AstraZeneca | 2020-09-18 |
| A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease (NCT04031469) | ProgenaBiome | 2019-07-11 |
| Effect of Different Dietary Therapies on Intestinal Barrier Integrity in Patients With Irritable Bowel Syndrome (NCT06421922) | Gulhane Training and Research Hospital | 2019-06-01 |
| Effect of HMOs as Nutritional Support for Normal Bowel Movements in IBS Patients (NCT03550742) | Glycom, Inc. | 2018-05-14 |
| Mode of Action of Butyrate in the Human Colon (NCT05249023) | Örebro University, Sweden | 2018-04-11 |
| Irritable Bowel Syndrome Survey in Gastroenterological Adult Outpatients in China (NCT02955316) | AstraZeneca | 2017-02-10 |
| qQ-lab Daily-IBS for Irritable Bowel Syndrome (NCT03964103) | IlDong Pharmaceutical Co Ltd | 2016-10-04 |
| Effects of HMOs on Faecal Microbiota, Gastrointestinal Symptoms, Mucosal Immunity and Barrier Function in IBS Patients (NCT02875847) | Glycom A/S | 2016-09-01 |
| Genetic Determinism of Epithelial Barrier Defects in Irritable Bowel Syndrome (NCT02841878) | Centre Hospitalier Universitaire de Nice | 2016-09-01 |
| Confocal Endomicroscopy Utility (p-CLE) in Irritable Bowel Syndrome (NCT02651532) | Instituto Ecuatoriano de Enfermedades Digestivas | 2016-01-01 |
| Indiana University Gastrointestinal Motility Diagnosis Registry (NCT04506593) | Indiana University | 2014-11-01 |
| Microbiome Fructan Metabolism and Symptoms in Childhood IBS (NCT02842281) | Baylor College of Medicine | 2014-09-01 |
| Collaborative Cognitive Behavioral Therapy / Hypnotherapy for Treatment of Pediatric Functional Gastrointestinal Disease (NCT01966341) | Seton Healthcare Family | 2014-04-01 |
| Cognitive Behavior Therapy (CBT) for Children With Functional Gastrointestinal Disorders (NCT02113605) | Karolinska Institutet | 2014-04-01 |
| Peripheral Histamine 1 Receptor Blockade in IBS: Multicenter Trial (NCT01908465) | KU Leuven | 2013-11-01 |
| Fecal Microbiota Transplantation in Patients With Irritable Bowel Syndrome (NCT02092402) | Örebro University, Sweden | 2013-09-01 |
| Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) (NCT01887002) | Ono Pharma USA Inc | 2013-06-01 |
| A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) (NCT01844180) | Ono Pharma USA Inc | 2013-04-01 |
| The Diagnostic Predictability of Food Allergy Testing (NCT01791621) | The Canadian College of Naturopathic Medicine | 2013-01-01 |
| Physical Activity in IBS - a Long Term Follow up (NCT01774695) | Sahlgrenska University Hospital | 2011-06-01 |
| Microbe-Gut Interaction in Microscopic Colitis and Post-Infectious Irritable Bowel Syndrome (IBS) (NCT01787253) | Örebro University, Sweden | 2010-11-01 |
| Abdominal Symptom Phenotype Study in Children (NCT01204515) | Baylor College of Medicine | 2010-06-01 |
| Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents (NCT01118988) | University of California, Los Angeles | 2009-12-01 |
| Tolerability and Effectiveness of Progut in Treatment of Irritable Bowel Syndrome (NCT00904696) | National University Hospital, Singapore | 2009-05-01 |
| Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide (NCT00584298) | Novartis | 2008-01-01 |
| Study On The Effect Of GW876008 On Cerebral Blood Flow In Irritable Bowel Syndrome (IBS) Patients And Healthy Volunteers (NCT00376896) | GlaxoSmithKline | 2006-11-01 |
| Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome (NCT00421707) | GlaxoSmithKline | 2006-10-14 |
| A Study To Investigate The Effect Of Solabegron (GW427353) On Gastrointestinal Transit In Healthy Volunteers (NCT00401479) | GlaxoSmithKline | 2006-10-01 |
| A Study To Investigate GW427353 In Subjects With Irritable Bowel Syndrome (IBS) (NCT00394186) | GlaxoSmithKline | 2006-08-01 |
| Pilot Study to Assess the Effects of AV608 on Irritable Bowel Syndrome (NCT00316550) | Avera Pharmaceuticals | 2006-04-01 |
| Study to Determine the Effectiveness of the Probiotic E. Coli Strain M17 in Treating Irritable Bowel Syndrome (IBS) (NCT00194922) | Weill Medical College of Cornell University | 2004-08-01 |
| Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy (NCT00067561) | GlaxoSmithKline | 2003-06-01 |